Therapy of scleritis with cytotoxic agents.
Four patients with severe anterior scleritis that had not responded to conventional therapy were treated with cytotoxic immunosuppressive alkylating agents alone (one case) or in combination with prednisone (three cases). Two of the patients had Wegener's granulomatosis, one pyoderma gangrenosum, and one rheumatoid vasculitis. All patients responded well to this therapy with a decrease in inflammation and a healing of the sclera. Other systemic manifestations of the underlying diseases often responded well also.
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003622:Dapsone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005128:Eye Diseases / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005469:Fluorometholone / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D008875:Middle Aged; D009883:Ophthalmic Solutions; D011241:Prednisone / Q000008:administration & dosage; D012590:Sclera / Q000187:drug effects
D000970:Antineoplastic Agents; D009883:Ophthalmic Solutions; D008466:Mechlorethamine; D003520:Cyclophosphamide; D003622:Dapsone; D005469:Fluorometholone; D011241:Prednisone